Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,333,582 |
|
|||||
| News | (1) | ||||||
| Day High | 33.85 | Low High |
|||||
| Day Low | 32.46 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biohaven Ltd | BHVN | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.38 | 1.14% | 33.70 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 33.20 | 32.46 | 33.85 | 33.66 | 33.32 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,055 | 1,333,582 | US$ 33.27 | US$ 44,371,779 | - | 12.35 - 33.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:00:00 | 150,933 | US$ 33.66 | USD |
Biohaven Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 2.70B | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biohaven News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.26 | 33.99 | 29.76 | 32.12 | 1,123,313 | 3.44 | 11.37% |
| 1 Month | 29.84 | 33.99 | 26.93 | 30.30 | 1,098,517 | 3.86 | 12.94% |
| 3 Months | 19.25 | 33.99 | 16.45 | 26.05 | 1,246,931 | 14.45 | 75.06% |
| 6 Months | 18.20 | 33.99 | 16.45 | 23.96 | 1,149,825 | 15.50 | 85.16% |
| 1 Year | 15.90 | 33.99 | 12.35 | 19.94 | 1,079,551 | 17.80 | 111.95% |
| 3 Years | 89.58 | 152.56 | 7.10 | 69.18 | 951,685 | -55.88 | -62.38% |
| 5 Years | 36.15 | 152.56 | 7.10 | 63.30 | 866,014 | -2.45 | -6.78% |
Biohaven Description
| Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. |
